Emerg Infect DiseidEmerging Infectious Diseases1080-60401080-6059Centers for Disease Control100816832627701Research ArticleStaphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia.RotunS. S.McMathV.SchoonmakerD. J.MaupinP. S.TenoverF. C.HillB. C.AckmanD. M.United Hospital Medical Center (UHMC), Port Chester, New York, USA.Jan-Feb199951147149

A Staphylococcus aureus isolate with reduced susceptibility to vancomycin was obtained from a dialysis patient with a fatal case of bacteremia. Comparison of the isolate with two methicillin-resistant S. aureus (MRSA) isolated obtained from the same patient 4 months earlier suggests that the S. aureus with reduced susceptibility to vancomycin emerged from the MRSA strain with which the patient was infected. Atypical phenotypic characteristics, including weak or negative latex-agglutination test results, weak or negative-slide coagulase test results, heterogeneous morphologic features, slow rate of growth, and vancomycin susceptibility (by disk diffusion test) were observed.